Evidence map›Paper›PMID 29140226›Full record

ArticlePsychological medicine2018

Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study.

G M Khandaker, J Stochl, S Zammit, I Goodyer, G Lewis, P B Jones

Open access · hybridAbstract read
In one paragraph

Article in Psychological medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Neurobiology of resilience to early life stress.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

G M KhandakerDepartment of Psychiatry,University of Cambridge,Cambridge,UK.
J StochlDepartment of Psychiatry,University of Cambridge,Cambridge,UK.
S ZammitCentre for Mental Health,Addiction and Suicide Research,School of Social and Community Medicine,University of Bristol,Bristol,UK.
I GoodyerDepartment of Psychiatry,University of Cambridge,Cambridge,UK.
G LewisDivision of Psychiatry,University College London,London,UK.
P B JonesDepartment of Psychiatry,University of Cambridge,Cambridge,UK.
Cambridgeshire and Peterborough NHS Foundation Trust · GBUniversity of Cambridge · GBCentre for Mental Health · GBUniversity College London · GB

Funding

Department of Health RP-PG-0606-1335Medical Research Council 74882Medical Research Council MC_PC_13042Medical Research Council MR/K006665/1Wellcome TrustWellcome Trust 088869/Z/09/ZWellcome Trust 092731Wellcome Trust 095844/Z/11/ZWellcome Trust 201486/Z/16/Z
6 · The paper itself

Abstract

backgroundTo identify developmental sub-groups of depressive symptoms during the second decade of life, a critical period of brain development, using data from a prospective birth cohort. To test whether childhood intelligence and inflammatory markers are associated with subsequent persistent depressive symptoms.

methodsIQ, a proxy for neurodevelopment, was measured at age 8 years. Interleukin 6 (IL-6) and C-reactive protein, typical inflammatory markers, were measured at age 9 years. Depressive symptoms were measured six times between 10 and 19 years using the short mood and feelings questionnaire (SMFQ), which were coded as binary variable and then used in latent class analysis to identify developmental sub-groups of depressive symptoms.

resultsLongitudinal SMFQ data from 9156 participants yielded three distinct population sub-groups of depressive symptoms: no symptoms (81.2%); adolescent-onset symptoms (13.2%); persistent symptoms (5.6%). Lower IQ and higher IL-6 levels in childhood were independently associated with subsequent persistent depressive symptoms in a linear, dose-response fashion, but not with adolescent-onset symptoms. Compared with the group with no symptoms the adjusted odds ratio for persistent depressive symptoms per s.d. increase in IQ was 0.80 (95% CI, 0.68-0.95); that for IL-6 was 1.20 (95% CI, 1.03-1.39). Evidence for an association with IL-6 remained after controlling for initial severity of depressive symptoms at 10 years. There was no evidence that IL-6 moderated or mediated the IQ-persistent depressive symptom relationship.

conclusionsThe results indicate potentially important roles for two distinct biological processes, neurodevelopment and inflammation, in the aetiology of persistent depressive symptoms in young people.

Indexed as

IntelligenceAdolescentBiomarkersChildC-Reactive ProteinDepressionEnglandFemaleHumansInflammationIntelligence TestsInterleukin-6Logistic ModelsLongitudinal StudiesMalePredictive Value of TestsBiomarkersC-Reactive ProteinIL6 protein, humanInterleukin-6CRPdepressiondepressive symptomsIL-6immunopsychiatryinflammationintelligenceIQlatent class analysislongitudinal studyneurodevelopment

Identifiers

PMID29140226
PMCPMC6088526
OpenAlexW2725712364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.